Menu

Explore Ocular Drug Delivery With Us

Northern Bio offers comprehensive expertise and cutting-edge technologies to advance the development and evaluation of therapies for ocular diseases, ensuring precise assessments and robust data in the preclinical stage of ophthalmology.

Innovative Eye Disease Research

Northern Bio supports the development of innovative therapies and devices for a wide range of eye diseases and disorders. These may include conditions such as age-related macular degeneration, diabetic retinopathy, glaucoma, and dry eye syndrome. By leveraging advanced administration and imaging technologies, the services offered at Northern Bio provide precise evaluations to drive therapeutic advancements and regulatory approval in the preclinical space.
scientist using lab computer

Consult a Scientist

We are a team of scientists who value open communication and collaboration. We work closely with our sponsors to provide customized solutions and expert support.

Consult a scientist

Targeted Delivery

Northern Bio supports the development of diverse therapeutic modalities, including biologics, gene therapies (AAVs), RNA-based treatments, and small molecules. Targeted delivery approaches, such as intravitreal, intracameral, intracorneal, subretinal, suprachoroidal, and topical administrations, ensure precise delivery to specific ocular tissues for toxicological and efficacious assessment.

Instrumentation & Capabilities

Equipment

Kowa SL-17 slit lamp
Heine Omega 500 indirect ophthalmoscope
Reichert Tonovet/Tonolab
RetCam III widefield color fundus camera
Top-Con TRC50-DX color fundus camera
Heidelberg Engineering Spectralis 6-mode OCT/cSLO
Bausch & Lomb Stellaris Elite anterior/posterior surgical
Alcon Accurus anterior/posterior surgical
Zeiss OPMI CS/S4 operating microscope
Roland Consult Electroretinography Unit

Routes of administration

Intracorneal
Intravitreal
Periocular
Intracameral
Suprachoroidal
Subretinal

Species

Rabbit
Canine
NHP
Swine

Frequently Asked Questions (FAQs) about Ophthalmology

Ocular routes of administration offer a unique challenge in ensuring that the therapeutic reaches the targeted regions of the eye. Northern Bio offers unique capabilities of dosing intracorneal, intravitreal, periocular, intracameral, suprachoroidal, subretinal, etc., to ensure that the therapies that we work with reach the intended targets to maximize efficacy assessment.

Partner With Us

Let’s work together to develop
life-changing treatments.

Join us in the pursuit of better lives through scientific innovation. Explore how Northern Bio can help you achieve your research goals.

CONSULT A SCIENTIST